Invesco Ltd. lifted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 28.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,327,021 shares of the company's stock after purchasing an additional 294,180 shares during the period. Invesco Ltd. owned 2.32% of Molina Healthcare worth $386,229,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of MOH. Polymer Capital Management US LLC bought a new stake in Molina Healthcare during the 4th quarter valued at $229,000. Cerity Partners LLC increased its stake in Molina Healthcare by 114.1% in the 4th quarter. Cerity Partners LLC now owns 11,598 shares of the company's stock worth $3,482,000 after acquiring an additional 6,180 shares during the last quarter. FMR LLC raised its holdings in shares of Molina Healthcare by 31.1% in the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after acquiring an additional 427,276 shares in the last quarter. Federated Hermes Inc. boosted its position in shares of Molina Healthcare by 28.3% during the 4th quarter. Federated Hermes Inc. now owns 49,121 shares of the company's stock valued at $14,297,000 after acquiring an additional 10,832 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its holdings in shares of Molina Healthcare by 11.4% during the fourth quarter. Quadrant Capital Group LLC now owns 627 shares of the company's stock worth $182,000 after purchasing an additional 64 shares in the last quarter. Institutional investors own 98.50% of the company's stock.
Analyst Upgrades and Downgrades
MOH has been the subject of a number of research reports. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Mizuho increased their price objective on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial boosted their target price on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday. Barclays reduced their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research report on Friday, February 7th. Finally, UBS Group lowered their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Eight equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Molina Healthcare presently has an average rating of "Moderate Buy" and an average target price of $359.42.
Check Out Our Latest Analysis on MOH
Molina Healthcare Stock Down 3.7 %
Shares of MOH stock traded down $12.75 during trading hours on Tuesday, hitting $335.82. 232,709 shares of the company's stock traded hands, compared to its average volume of 652,377. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a market cap of $18.37 billion, a price-to-earnings ratio of 16.44, a PEG ratio of 1.06 and a beta of 0.70. The stock's fifty day simple moving average is $311.02 and its two-hundred day simple moving average is $308.02. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $373.22.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Insider Activity at Molina Healthcare
In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.10% of the stock is currently owned by insiders.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
